Ocrelizumab (Ocrevus) Gets CHMP Nod for Multiple Sclerosis Ocrelizumab (Ocrevus) Gets CHMP Nod for Multiple Sclerosis

The EMA committee recommends ocrelizumab for adults with relapsing multiple sclerosis and early primary progressive multiple sclerosis.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news